carbostyril has been researched along with Pervasive Child Development Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 18 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lord, C; Moyal, WN; Walkup, JT | 1 |
| Ameis, SH; Cole, L; Corbett-Dick, P; Correll, CU | 1 |
| Arshad, E; Deb, S; Deb, T; Farmah, BK; Roy, M; Unwin, GL | 1 |
| Early, M; Erickson, CA; Horn, P; McDougle, CJ; Pottenger, A; Schaefer, T; Wink, LK | 1 |
| Adler, BA; Early, M; Erickson, CA; McDougle, CJ; Minshawi, N; Shaffer, R; Wink, LK | 1 |
| Frazier, J; Maloney, A; Mick, EO | 1 |
| Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA | 2 |
| Cosenza, A; Masi, G; Millepiedi, S; Muratori, F; Pari, C; Salvadori, F | 1 |
| Diener, JT; Erickson, CA; Kohn, AE; Li, L; McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
| Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z | 1 |
| Fitzgerald, ME; Fodstad, JC; Matson, JL; Sipes, M | 1 |
| Asano, M; Hiratani, M; Ishitobi, M; Kosaka, H; Mizuno, T; Murata, T; Takahashi, T; Tomoda, A; Wada, Y | 1 |
| Chadman, KK; Guariglia, SR; Yoo, JH | 1 |
| Catani, M; Craig, M; Jordan, I; Murphy, D; Robertson, D | 1 |
| Bivas, R; Chahal, L; Fung, LK; Hardan, AY; Libove, RA | 1 |
| Ching, H; Pringsheim, T | 1 |
| Caldwell, RL; Erickson, CA; Ho, JG; McDougle, CJ; Orsagh-Yentis, DK; Posey, DJ; Stigler, KA | 1 |
| Nightingale, S | 1 |
| Yui, K | 1 |
| Aman, MG; Arnold, LE; Butter, E; Handen, B; Humphries, K; Lecavalier, L; Li, X; McDougle, CJ; Scahill, L; Stigler, KA; Swiezy, NB; Wilson, K | 1 |
| McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
| Murphy, TK; Negin, B | 1 |
| Delgado, SV; Strawn, JR | 1 |
8 review(s) available for carbostyril and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Quality of life in children and adolescents with autism spectrum disorders: what is known about the effects of pharmacotherapy?
Topics: Adolescent; Aripiprazole; Child; Child Development Disorders, Pervasive; Comorbidity; Humans; Oxytocin; Piperazines; Psychopharmacology; Psychotropic Drugs; Quality of Life; Quinolones | 2014 |
The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Child Development Disorders, Pervasive; Developmental Disabilities; Humans; Intellectual Disability; Mental Disorders; Piperazines; Quinolones; Self-Injurious Behavior; Treatment Outcome | 2014 |
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2008 |
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Fragile X Syndrome; Humans; Piperazines; Quinolones | 2010 |
A systematic review of medical treatments for children with autism spectrum disorders.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome | 2011 |
Issues in the management of challenging behaviours of adults with autism spectrum disorder.
Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Behavior Therapy; Child; Child Development Disorders, Pervasive; Combined Modality Therapy; Humans; Piperazines; Quinolones; Risperidone | 2011 |
New directions in the treatment of autism spectrum disorders from animal model research.
Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2012 |
Aripiprazole for autism spectrum disorders (ASD).
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Female; Humans; Hyperkinesis; Irritable Mood; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic | 2012 |
4 trial(s) available for carbostyril and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Treatment Outcome | 2014 |
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Body Mass Index; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Irritable Mood; Male; Pilot Projects; Piperazines; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychometrics; Quinolones; Severity of Illness Index | 2009 |
The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Child; Child Development Disorders, Pervasive; Child, Preschool; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Irritable Mood; Male; Pilot Projects; Piperazines; Prospective Studies; Quinolones | 2012 |
Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Child, Preschool; Combined Modality Therapy; Comorbidity; Female; Follow-Up Studies; Humans; Male; Parents; Patient Education as Topic; Piperazines; Quinolones; Risperidone; Treatment Outcome | 2012 |
12 other study(ies) available for carbostyril and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Piperazines; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Quinolones; Risk Assessment; Risperidone | 2013 |
Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Body Mass Index; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Risperidone; Weight Gain; Young Adult | 2014 |
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Intellectual Disability; Male; Middle Aged; Pilot Projects; Piperazines; Quinolones; Retrospective Studies; Risk Factors; Risperidone; Self-Injurious Behavior; Treatment Failure; Young Adult | 2015 |
Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Chi-Square Distribution; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Severity of Illness Index | 2009 |
Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone.
Topics: Adolescent; Aripiprazole; Child; Child Development Disorders, Pervasive; Drug Substitution; Female; Humans; Male; Piperazines; Quinolones; Retrospective Studies; Risperidone; Treatment Outcome; Young Adult | 2012 |
Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Behavior; Child; Child Development Disorders, Pervasive; Female; Humans; Male; Piperazines; Quinolones; Treatment Outcome; Young Adult | 2012 |
A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Registries; Retrospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors | 2012 |
Autism spectrum disorders.
Topics: Adolescent; Aripiprazole; Child Development Disorders, Pervasive; Child, Preschool; Clinical Trials as Topic; Humans; Piperazines; Quinolones; Risperidone | 2012 |
[Useful pharmacologic treatment in impaired social interaction in autism spectrum disorders].
Topics: Administration, Inhalation; Antipsychotic Agents; Arachidonic Acid; Aripiprazole; Child Development Disorders, Pervasive; Child, Preschool; Humans; Interpersonal Relations; Oxytocin; Piperazines; Quinolones; Risperidone | 2012 |
Aripiprazole for maladaptive behavior in pervasive developmental disorders.
Topics: Adolescent; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones | 2004 |
Priapism associated with oxcarbazepine, aripiprazole, and lithium.
Topics: Adolescent; Affective Symptoms; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Child; Child Development Disorders, Pervasive; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Oxcarbazepine; Penile Erection; Piperazines; Priapism; Quinolones | 2005 |
Successful treatment of catatonia with aripiprazole in an adolescent with psychosis.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Catatonia; Child Development Disorders, Pervasive; Child, Preschool; Female; Hospitalization; Humans; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones | 2007 |